“

RSV is an enormous problem, particularly for children but also for adults. RSV could produce as much illness as does influenza at least in some years, these are exciting potential advances. We will see them develop as several products come to maturation and come before the Food and Drug Administration for licensure this year or next year. It’s going to be an exciting time.